Jessica Silva Barbosa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jessica Silva Barbosa has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Filipe Alexandre Almeida Paz
CICECO—Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal
9 shared publications - Susana Santos Braga
LAQV‐REQUIMTE, Department of Chemistry University of Aveiro Aveiro Portugal
7 shared publications - Firas El-Saleh
Ashland Specialty Ingredients, Paul-Thomas Strasse, 56, D-40599 Düsseldorf, Germany
2 shared publications Flávio Figueira
Department of Chemistry, CICECO—Aveiro Institute of Materials University of Aveiro 3810-193 Aveiro Portugal
2 shared publications- João Rocha
CICECO-Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
2 shared publications - Nádia E. Santos
LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
2 shared publications
Latest Publications
- Open Access
- 27 August 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (35) , 11088
Correction: Polymeric nanocarriers for cancer treatment: the promise of sensitive poly(2-(diisopropylamino)ethyl methacrylate)
Correction for ‘Polymeric nanocarriers for cancer treatment: the promise of sensitive poly(2-(diisopropylamino)ethyl methacrylate)’ by Joana S. Ferreira et al. , J. Mater. Chem. B , 2025, 13 , 7000–7013, https://doi.org/10.1039/D5TB00268K.
- 27 August 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (35) , 11088
Open AccessCorrection: Polymeric nanocarriers for cancer treatment: the promise of sensitive poly(2-(diisopropylamino)ethyl methacrylate)
Correction for ‘Polymeric nanocarriers for cancer treatment: the promise of sensitive poly(2-(diisopropylamino)ethyl methacrylate)’ by Joana S. Ferreira et al. , J. Mater. Chem. B , 2025, 13 , 7000–7013, https://doi.org/10.1039/D5TB00268K.
- Open Access
- 24 February 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (3) , 499
Correction: Braga et al. Cyclodextrins in Antiviral Therapeutics and Vaccines. Pharmaceutics 2021, 13, 409
- 24 February 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (3) , 499
Open AccessCorrection: Braga et al. Cyclodextrins in Antiviral Therapeutics and Vaccines. Pharmaceutics 2021, 13, 409
- Open Access
- 19 March 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3) , 409
Cyclodextrins in Antiviral Therapeutics and Vaccines
The present review describes the various roles of cyclodextrins (CDs) in vaccines against viruses and in antiviral therapeutics. The first section describes the most commonly studied application of cyclodextrins—solubilisation and stabilisation of antiviral drugs; some examples also refer to their beneficial taste-masking activity. The second part of the review describes the role of cyclodextrins in antiviral vaccine development and stabilisation, where they are employed as adjuvants and cryopreserving agents. In addition, cyclodextrin-based polymers as delivery systems for mRNA are currently under development. Lastly, the use of cyclodextrins as pharmaceutical active ingredients for the treatment of viral infections is explored. This new field of application is still taking its first steps. Nevertheless, promising results from the use of cyclodextrins as agents to treat other pathologies are encouraging. We present potential applications of the results reported in the literature and highlight the products that are already available on the market.
- 19 March 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3) , 409
Open AccessCyclodextrins in Antiviral Therapeutics and Vaccines
The present review describes the various roles of cyclodextrins (CDs) in vaccines against viruses and in antiviral therapeutics. The first section describes the most commonly studied application of cyclodextrins—solubilisation and stabilisation of antiviral drugs; some examples also refer to their beneficial taste-masking activity. The second part of the review describes the role of cyclodextrins in antiviral vaccine development and stabilisation, where they are employed as adjuvants and cryopreserving agents. In addition, cyclodextrin-based polymers as delivery systems for mRNA are currently under development. Lastly, the use of cyclodextrins as pharmaceutical active ingredients for the treatment of viral infections is explored. This new field of application is still taking its first steps. Nevertheless, promising results from the use of cyclodextrins as agents to treat other pathologies are encouraging. We present potential applications of the results reported in the literature and highlight the products that are already available on the market.
- Open Access
- 1 December 2020
- Published by MDPI AG in Proceedings
- Vol. 78 (1) , 18
Inclusion of Montelukast in y-Cyclodextrin: Presenting a Mechanochemical Route to Improve Drug Stability and Solubility
Montelukast sodium (MLK) is a worldwide antiasthmatic drug. Commercial formulations still have some issues with solubility and instability to light and humidity. To overcome them, the present work reports inclusion compounds of MLK and γ-cyclodextrin (γ-CD). As a molecular capsule, CDs have the ability to protect the inclusion guest from degradation, enhance its solubility and alter the pharmacokinetic parameters. MLKγ-CD inclusion compounds were prepared by mechanochemistry. Without using any solvent, γ-CD was pre-milled and then co-milled with an equimolar quantity of MLK in a ball mill at 600 cycles·min−1. After 120 min of milling, the formation of MLK·γ-CD inclusion compounds was confirmed by powder X-ray diffraction and scanning electron microscopy. Additional studies, performed under pharmacopeia guidelines, showed that the prepared MLKγ-CD inclusion compounds can indeed increase the dissolution of MLK when in ultrapure water or simulated intestinal fluid (without pancreatin). This way, the MLKγ-CD inclusion compounds that are presented in this work are a promising solution for improving the therapeutic effectiveness of MLK.
- 1 December 2020
- Published by MDPI AG in Proceedings
- Vol. 78 (1) , 18
Open AccessInclusion of Montelukast in y-Cyclodextrin: Presenting a Mechanochemical Route to Improve Drug Stability and Solubility
Montelukast sodium (MLK) is a worldwide antiasthmatic drug. Commercial formulations still have some issues with solubility and instability to light and humidity. To overcome them, the present work reports inclusion compounds of MLK and γ-cyclodextrin (γ-CD). As a molecular capsule, CDs have the ability to protect the inclusion guest from degradation, enhance its solubility and alter the pharmacokinetic parameters. MLKγ-CD inclusion compounds were prepared by mechanochemistry. Without using any solvent, γ-CD was pre-milled and then co-milled with an equimolar quantity of MLK in a ball mill at 600 cycles·min−1. After 120 min of milling, the formation of MLK·γ-CD inclusion compounds was confirmed by powder X-ray diffraction and scanning electron microscopy. Additional studies, performed under pharmacopeia guidelines, showed that the prepared MLKγ-CD inclusion compounds can indeed increase the dissolution of MLK when in ultrapure water or simulated intestinal fluid (without pancreatin). This way, the MLKγ-CD inclusion compounds that are presented in this work are a promising solution for improving the therapeutic effectiveness of MLK.
- Open Access
- 1 December 2020
- Published by Wiley in Chemistry – A European Journal
- Vol. 26 (67)
Frontispiece: Bone Tissue Disorders: Healing Through Coordination Chemistry
- 1 December 2020
- Published by Wiley in Chemistry – A European Journal
- Vol. 26 (67)
Open AccessFrontispiece: Bone Tissue Disorders: Healing Through Coordination Chemistry
- Open Access
Empowering the Medicinal Applications of Bisphosphonates by Unveiling their Synthesis Details
Bisphosphonates (BPs), well-known medicinal compounds used for osteoporosis management, are currently the target of intensive research, from basic pre-formulation studies to more advanced stages of clinical practice. The high demand by the pharmaceutical industry inherently requires an easy, efficient and quick preparation of BPs. Current synthetic procedures are, however, still far from ideal. This work presents a comprehensive compilation of reports on the synthesis of the commercially available bisphosphonates that are pharmaceutical active ingredients. Current limitations to the conventional synthesis are assessed, and paths towards their improvement are described, either through the use of alternative solvents and/or by selecting appropriate ratios of the reactants. Innovative processes, such as microwave-assisted synthesis, are presented as more environmental-friendly and effective methods. The main advantages and setbacks of all syntheses are provided as a way to clarify and promote the development of simpler and improved procedures. Only in this way one will be able to efficiently respond to the future high demand of BPs, mostly due to the increase in life span in occidental countries.
Open AccessEmpowering the Medicinal Applications of Bisphosphonates by Unveiling their Synthesis Details
Bisphosphonates (BPs), well-known medicinal compounds used for osteoporosis management, are currently the target of intensive research, from basic pre-formulation studies to more advanced stages of clinical practice. The high demand by the pharmaceutical industry inherently requires an easy, efficient and quick preparation of BPs. Current synthetic procedures are, however, still far from ideal. This work presents a comprehensive compilation of reports on the synthesis of the commercially available bisphosphonates that are pharmaceutical active ingredients. Current limitations to the conventional synthesis are assessed, and paths towards their improvement are described, either through the use of alternative solvents and/or by selecting appropriate ratios of the reactants. Innovative processes, such as microwave-assisted synthesis, are presented as more environmental-friendly and effective methods. The main advantages and setbacks of all syntheses are provided as a way to clarify and promote the development of simpler and improved procedures. Only in this way one will be able to efficiently respond to the future high demand of BPs, mostly due to the increase in life span in occidental countries.
- Open Access
Coordination Polymers Based on a Biphenyl Tetraphosphonate Linker: Synthesis Control and Photoluminescence
In this work, we used the rigid tetrapodal organic linker, [1,1′-biphenyl]-3,3′,5,5′-tetrayltetrakis(phosphonic acid) (H8btp), for the preparation of two lanthanide–organic framework families of compounds: layered [Ln7(H5btp)4(H5.5btp)2(H6btp)2(H2O)12]∙23.5H2O∙MeOH [where Ln3+ = Eu3+ (1Eu) and Gd3+ (1Gd)], prepared using microwave-irradiation followed by slow evaporation; 3D [Ln4(H3btp)(H4btp)(H5btp)(H2O)8]∙3H2O [where Ln3+ = Ce3+ (2Ce), Pr3+ (2Pr), and Nd3+ (2Nd)], obtained from conventional hydro(solvo)thermal synthesis. It is shown that in this system, by carefully selecting the synthetic method and the metal centers, one can increase the dimensionality of the materials, also increasing structural robustness (particularly to the release of the various solvent molecules). Compound 1 is composed of 2D layers stacked on top of each other and maintained by weak π–π interactions, with each layer formed by discrete 1D organic cylinders stacked in a typical brick-wall-like fashion, with water molecules occupying the free space in-between cylinders. Compound 2, on the other hand, is a 3D structure with small channels filled with crystallization water molecules. A full solid-state characterization of 1 and 2 is presented (FT-IR spectroscopy, SEM microscopy, thermogravimetric studies, powder X-ray diffraction and thermodiffractometry). The photoluminescence of 1Eu was investigated.
Open AccessCoordination Polymers Based on a Biphenyl Tetraphosphonate Linker: Synthesis Control and Photoluminescence
In this work, we used the rigid tetrapodal organic linker, [1,1′-biphenyl]-3,3′,5,5′-tetrayltetrakis(phosphonic acid) (H8btp), for the preparation of two lanthanide–organic framework families of compounds: layered [Ln7(H5btp)4(H5.5btp)2(H6btp)2(H2O)12]∙23.5H2O∙MeOH [where Ln3+ = Eu3+ (1Eu) and Gd3+ (1Gd)], prepared using microwave-irradiation followed by slow evaporation; 3D [Ln4(H3btp)(H4btp)(H5btp)(H2O)8]∙3H2O [where Ln3+ = Ce3+ (2Ce), Pr3+ (2Pr), and Nd3+ (2Nd)], obtained from conventional hydro(solvo)thermal synthesis. It is shown that in this system, by carefully selecting the synthetic method and the metal centers, one can increase the dimensionality of the materials, also increasing structural robustness (particularly to the release of the various solvent molecules). Compound 1 is composed of 2D layers stacked on top of each other and maintained by weak π–π interactions, with each layer formed by discrete 1D organic cylinders stacked in a typical brick-wall-like fashion, with water molecules occupying the free space in-between cylinders. Compound 2, on the other hand, is a 3D structure with small channels filled with crystallization water molecules. A full solid-state characterization of 1 and 2 is presented (FT-IR spectroscopy, SEM microscopy, thermogravimetric studies, powder X-ray diffraction and thermodiffractometry). The photoluminescence of 1Eu was investigated.
- 1 January 2020
- Published by Elsevier
- p. 69-92
Metal-organic frameworks for biomedical applications: The case of functional ligands
- 1 January 2020
- Published by Elsevier
- p. 69-92
Metal-organic frameworks for biomedical applications: The case of functional ligands
- Open Access
- 3 October 2019
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 75 (11) , 1607-1612
One-dimensional ladder gallium coordination polymer
A one-dimensional ladder-type coordination polymer, poly[[(μ2-hydroxido)(μ2-1H-pyrazole-3,5-dicarboxylato)gallium(III)] monohydrate], [Ga(C5H2N2O4)(OH)(H2O)] n or [Ga(HPDC)(OH)(H2O)] n , I, isotypic with a V3+ coordination polymer previously reported by Chen et al. [J. Coord. Chem. (2008). 61, 3556–3567] was prepared from Ga3+ and pyrazole-3,5-dicarboxylic acid monohydrate (H3PDC·H2O). Compound I was isolated using three distinct experimental methods: hydrothermal (HT), microwave-assisted (MWAS) and one-pot (OP) and the crystallite size should be fine-tuned according to the method employed. The coordination polymeric structure is based on a dimeric Ga3+ moiety comprising two μ2-bridging hydroxide groups, which are interconnected by HPDC2− anionic organic linkers. The close packing of individual polymers is strongly directed by the supramolecular interactions, namely several O—H...O and N—H...O hydrogen-bonding interactions.
- 3 October 2019
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 75 (11) , 1607-1612
Open AccessOne-dimensional ladder gallium coordination polymer
A one-dimensional ladder-type coordination polymer, poly[[(μ2-hydroxido)(μ2-1H-pyrazole-3,5-dicarboxylato)gallium(III)] monohydrate], [Ga(C5H2N2O4)(OH)(H2O)] n or [Ga(HPDC)(OH)(H2O)] n , I, isotypic with a V3+ coordination polymer previously reported by Chen et al. [J. Coord. Chem. (2008). 61, 3556–3567] was prepared from Ga3+ and pyrazole-3,5-dicarboxylic acid monohydrate (H3PDC·H2O). Compound I was isolated using three distinct experimental methods: hydrothermal (HT), microwave-assisted (MWAS) and one-pot (OP) and the crystallite size should be fine-tuned according to the method employed. The coordination polymeric structure is based on a dimeric Ga3+ moiety comprising two μ2-bridging hydroxide groups, which are interconnected by HPDC2− anionic organic linkers. The close packing of individual polymers is strongly directed by the supramolecular interactions, namely several O—H...O and N—H...O hydrogen-bonding interactions.
- 1 May 2019
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 108 (5) , 1837-1847
Preformulation Studies of the γ-Cyclodextrin and Montelukast Inclusion Compound Prepared by Comilling
- 1 May 2019
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 108 (5) , 1837-1847
Preformulation Studies of the γ-Cyclodextrin and Montelukast Inclusion Compound Prepared by Comilling